Avion Wealth’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Avion Wealth’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13	Closed	-$1K	–	1253
2023 Q4	$1K	Hold	13	–	–	﹤0.01%	1058
2023 Q3	$0	Buy	+13	New	+$464	﹤0.01%	1283

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth's MRTX Position: Q1 2024 in Review

Avion Wealth sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 13 shares — an estimated $1K sold.

Avion Wealth first reported a position in MRTX in Q3 2023 and held it in 2 quarters. The position peaked at $1K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Avion Wealth reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Avion Wealth sold 13 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1K.
Avion Wealth first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Avion Wealth's Mirati Therapeutics, Inc. Common Stock position peaked at $1K in Q4 2023.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Avion Wealth's 13F filing for Q1 2024, filed 3 May 2024.